tiprankstipranks
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Compare Fulcrum Therapeutics (FULC) vs. Competitors

520 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Fulcrum Therapeutics
$7.90
$526.81M
-9.57
174.65%
6 Buy
1 Hold
1 Sell
Moderate Buy
Monopar Therapeutics Inc
$58.03
$387.61M
-35.28
77.56%
7 Buy
0 Hold
0 Sell
Strong Buy
ADC Therapeutics
$3.76
$477.69M
-3.14
210.74%
3 Buy
0 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$17.12
$1.44B
-33.72
344.58%
7 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$980.57M
513.36%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
FULC
Fulcrum Therapeutics
7.91
5.29
201.91%
MNPR
Monopar Therapeutics Inc
57.92
26.05
81.74%
ADCT
ADC Therapeutics
3.76
2.64
235.71%
OPT
GLUE
Monte Rosa Therapeutics
18.05
13.90
334.94%
INBX
Inhibrx Biosciences Inc
75.75
64.43
569.17%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts